DE69034042T2 - System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung - Google Patents

System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung

Info

Publication number
DE69034042T2
DE69034042T2 DE69034042T DE69034042T DE69034042T2 DE 69034042 T2 DE69034042 T2 DE 69034042T2 DE 69034042 T DE69034042 T DE 69034042T DE 69034042 T DE69034042 T DE 69034042T DE 69034042 T2 DE69034042 T2 DE 69034042T2
Authority
DE
Germany
Prior art keywords
medical agent
therapeutic
diagnostic treatment
normal clearance
obviate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69034042T
Other languages
English (en)
Other versions
DE69034042D1 (de
Inventor
W Maddock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitra Medical Lund Se AB
Original Assignee
MITRA MEDICAL TECHNOLOGY LUND AB
MITRA MEDICAL TECHNOLOGY LU AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MITRA MEDICAL TECHNOLOGY LUND AB, MITRA MEDICAL TECHNOLOGY LU AB filed Critical MITRA MEDICAL TECHNOLOGY LUND AB
Priority claimed from PCT/US1990/004341 external-priority patent/WO1991001749A1/en
Publication of DE69034042D1 publication Critical patent/DE69034042D1/de
Application granted granted Critical
Publication of DE69034042T2 publication Critical patent/DE69034042T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
DE69034042T 1989-08-02 1990-08-02 System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung Expired - Fee Related DE69034042T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38866489A 1989-08-02 1989-08-02
PCT/US1990/004341 WO1991001749A1 (en) 1989-08-02 1990-08-02 Method of treatment with medical agents

Publications (2)

Publication Number Publication Date
DE69034042D1 DE69034042D1 (de) 2003-04-03
DE69034042T2 true DE69034042T2 (de) 2003-07-17

Family

ID=23535010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69034042T Expired - Fee Related DE69034042T2 (de) 1989-08-02 1990-08-02 System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung

Country Status (6)

Country Link
US (2) US5474772A (de)
EP (1) EP1327454A3 (de)
AT (1) ATE233100T1 (de)
DE (1) DE69034042T2 (de)
DK (1) DK0436717T3 (de)
ES (1) ES2188580T3 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US7166295B1 (en) 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
WO2000002050A1 (en) * 1998-07-07 2000-01-13 Department Of Radiation Oncology, University Of Washington Trifunctional reagent for conjugation to a biomolecule
EP0954340B1 (de) * 1996-05-03 2007-06-27 Immunomedics, Inc. Zielgerichtete kombinations-immuntherapie für krebs
US7011812B1 (en) * 1996-05-03 2006-03-14 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
US5817770A (en) 1997-03-21 1998-10-06 Drug Abuse Sciences, Inc. Cocaethylene immunogens and antibodies
DE60129741T2 (de) * 2000-06-20 2008-04-30 Immunomedics, Inc. Zielgerichtete kombinationsimmuntherapie für krebs und infektionskrankheiten
WO2002030474A1 (en) * 2000-10-12 2002-04-18 Mitra Medical Technology Ab Kit for intraperitoneal administration and extracorpeal removal of a drug
EP1575507A2 (de) * 2002-04-02 2005-09-21 Scantibodies Laboratory, Inc. Verfahren und vorrichtungen zur behandlung von schweren peripheren bakteriellen infektionen
EP1507557A4 (de) * 2002-04-23 2006-06-14 Meir Strahilevitz Verfahren und vorrichtungen zum anzielen eines situs in einem säugetier und zur entfernung von spezies aus einem säugetier
WO2006017763A2 (en) * 2004-08-04 2006-02-16 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
US8295914B2 (en) 2004-11-16 2012-10-23 Medrad, Inc. Systems and methods of determining patient transfer functions and modeling patient response to a pharmaceutical injection
DK2990073T3 (en) 2004-11-24 2018-08-13 Bayer Healthcare Llc DEVICES AND SYSTEMS FOR DELIVERING FLUIDS
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP2097835B1 (de) 2006-12-29 2018-05-30 Bayer Healthcare LLC Patientenbasierte parametergenerierungssysteme für medizinische injektionsverfahren
EP2170165B1 (de) 2007-07-17 2018-12-05 Bayer Healthcare LLC Systeme zur bestimmung von parametern für ein verfahren zur schätzung der kardiopulmonalen funktion und zur flüssigkeitsabgabe
US8165663B2 (en) * 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US8285367B2 (en) * 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
US8317737B2 (en) 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US8246565B2 (en) * 2009-02-25 2012-08-21 The Invention Science Fund I, Llc Device for passively removing a target component from blood or lymph of a vertebrate subject
US8758330B2 (en) 2010-03-05 2014-06-24 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US8454547B2 (en) * 2009-02-25 2013-06-04 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
EP2585116A4 (de) 2010-06-24 2017-03-29 Bayer Healthcare LLC Modellierung einer pharmazeutikumsausbreitung und parametererstellung für injektionsprotokolle
CN111528872A (zh) 2012-05-14 2020-08-14 拜耳医药保健有限公司 用于基于x射线管电压确定药用流体注射协议的系统和方法
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
WO2017152036A1 (en) 2016-03-03 2017-09-08 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
EP3538546A1 (de) 2016-11-14 2019-09-18 Novartis AG Zusammensetzungen, verfahren und therapeutische verwendungen im zusammenhang mit fusogenem protein minion
AU2018323442A1 (en) 2017-08-31 2020-01-23 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance
CA3068544A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Method for dynamic pressure control in a fluid injector system
US11786652B2 (en) 2017-08-31 2023-10-17 Bayer Healthcare Llc System and method for drive member position and fluid injector system mechanical calibration
US11598664B2 (en) 2017-08-31 2023-03-07 Bayer Healthcare Llc Injector pressure calibration system and method
WO2019046267A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc SYSTEM AND METHOD FOR VOLUME COMPENSATION OF FLUID INJECTOR SYSTEM
GB201717555D0 (en) * 2017-10-25 2017-12-06 Nonwovens Innovation & Res Institute Ltd Blood filter

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4223672A (en) * 1979-02-08 1980-09-23 Baxter Travenol Laboratories, Inc. Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US4800016A (en) * 1986-11-24 1989-01-24 The University Of Michigan Extracorporeal blood de-heparinization system
DE3705637A1 (de) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren
US4846786A (en) * 1987-04-30 1989-07-11 Massachusetts Institute Of Technology Bioreactor containing suspended, immobilized species
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
DK0454783T3 (da) * 1989-01-23 1995-10-16 Akzo Nobel Nv Sted-specifik in vivo aktivering af terapeutiske lægemidler
US5252466A (en) * 1989-05-19 1993-10-12 Biotechnology Research And Development Corporation Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
CA2037933C (en) * 1989-08-02 2000-11-07 Stephen W. Maddock Method of treatment with medical agents
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal

Also Published As

Publication number Publication date
ES2188580T3 (es) 2003-07-01
US6046225A (en) 2000-04-04
DE69034042D1 (de) 2003-04-03
DK0436717T3 (da) 2003-05-05
US5474772A (en) 1995-12-12
EP1327454A2 (de) 2003-07-16
ATE233100T1 (de) 2003-03-15
EP1327454A3 (de) 2003-12-03

Similar Documents

Publication Publication Date Title
DE69034042D1 (de) System zur verwendung in einem verfahren zur therapeutischen und diagnostischen behandlung
DE59306276D1 (de) Verfahren und anordnung zur therapie von gewebe mit ultraschall
DE69204683D1 (de) Hämofiltrationssystem.
DE69121704D1 (de) Kombinationskatheter zur beobachtung und zur dilatation von blutgefässen
ATE66374T1 (de) Zubereitungen und verfahren zur behandlung von blutungsstoerungen.
DE3587266T2 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DK22489D0 (da) Fremgangsmaade og apparat til medicinsk behandling af den patologiske tilstand af knogler
DE69333866D1 (de) Gerät zur medizinischen Ultraschallbehandlung unter Verwendung von Computertomographie
Goldsmith et al. Prevention of cerebral infarction in the monkey by omental transposition to the brain.
DE60037116D1 (de) System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes
DE3685853T2 (de) Mittel zur behandlung von knochenkrankheiten.
Stone et al. Mobilization of Radioactive Sodium from the Gastrocnemius Muscle of the Dog.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
FR2548023B1 (fr) Medicament veterinaire et solution de bain de pieds pour le traitement du pietin des ovins
DE69119865T2 (de) Einrichtung zur medizinischen Behandlung
BE891629A (fr) Promoteur de coagulation du sang et procede l'utilisant
CA2037933A1 (en) Method of Treatment with Medical Agents
ATE249832T1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE355029T1 (de) Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
DE69430807T2 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
SU826588A1 (ru) Способ консервативного лечени неврологических синдромов при шейном остеохондрозе
UA136021U (uk) Спосіб лікування хронічної тріщини губ
UA20008A (uk) Спосіб визhачеhhя іhдивідуальhої чутливості до лікуваhhя методом траhсфузій опроміhеhої ультрафіолетом аутокрові хворих hа псоріаз

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MITRA MEDICAL AB, LUND, SE

8339 Ceased/non-payment of the annual fee